Abbvie Inc (ABBV) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abbvie Inc   (NYSE: ABBV)


Abbvie Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Abbvie Inc 's ROA in the second quarter of 2026?
Abbvie Inc achieved a return on average assets (ROA) of 4.68 % in its second quarter of 2026, which is below Abbvie Inc 's average return on assets, which stands at 7.96%.

ROA has improved compared to 2.69% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 159 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1669, from total ROA ranking in the first quarter of 2026 at 1841.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -1.51 % 0.42 % -0.69 % -6.64 % -3.35 %
Y / Y Net Income Change 284.27 % -45.93 % - -87.98 % -31.46 %
Net Income (TTM) in million 6,316 3,641 4,233 2,395 3,771
Return On Assets (TTM) 4.68 % 2.69 % 3.13 % 1.77 % 2.73 %
ABBV's Total Ranking # 1669 # 1841 # 1901 # 1641 # 1579
Total Assets (TTM) in million 135,115 136,731 134,228 133,898 137,182
Seq. Total Assets Change -1.18 % 1.86 % 0.25 % -2.39 % 0.75 %
Seq. Net Income Change 418.79 % -61.6 % 865.43 % -80.02 % -27 %

ABBV's 5 Years Annual ROA >> Back to ABBV Management Effectiveness >> Compare ABBV ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 60
Sector # 160
Overall # 1239

Return On Assets Statistics
High Average Low
16.46 %
7.96 %
1.77 %
(Sep. 30, 2013)   (Sep 30 2025)





Financial Statements
Abbvie Inc 's Assets $ 135,115 million ABBV's Balance sheet
Abbvie Inc 's Income $ 3,616 million Quarterly ABBV's Income Statement
ABBV's Income by Division See ABBV's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -0.69 % 0.33 % -2.95 % -5.27 % -2.68 %
Total Assets in million 134,228 135,161 134,711 138,805 146,529
Y / Y Net Income Change -1.24 % -12.05 % -58.86 % 2.56 % 149.87 %
Net Income in million 4,233 4,286 4,873 11,845 11,549
Annual Return On Assets 3.15 % 3.17 % 3.62 % 8.53 % 7.88 %

ABBV's 5 Years Annual ROA >> Back to ABBV Management Effectiveness >> Compare ABBV ROA to its Competitors



Comment on ABBV's ROA in the fiscal year ending 2025
In the fiscal year 2025 Abbvie Inc 's ROA decreased compared to previous year to 3.15 %, due to deterioration of net income -1.24 % to $4,233.00 million, from $4,286.00 million a year ago, as ABBV's assets were $134,228.00 million.


More Return On Assets Ratios
ABBV's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABBV's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABBV's Competitors
Subscribers only: Roa for Abbvie Inc 's Suppliers
Subscribers only: Return On Assets for ABBV's Customers

You may also want to know
ABBV's Roi ABBV's Inventory Turnover Ratio ABBV's Growth Rates ABBV's Dividend Comparisons
ABBV's Profitability Ratios ABBV's Asset Turnover Ratio ABBV's Dividend Growth
ABBV's Roe ABBV's Valuation Ratios ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Illumina Inc   12.68 %
Spero Therapeutics Inc   12.57 %
Transmedics Group Inc   12.50 %
Eton Pharmaceuticals Inc   12.37 %
Nephros Inc   12.30 %
Msa Safety Inc  12.23 %
Strata Critical Medical Inc   12.18 %
Insulet Corporation  12.13 %
Lantheus Holdings Inc   11.89 %
Ligand Pharmaceuticals Incorporated  11.68 %
Theravance Biopharma inc   11.68 %
Carlisle Companies Incorporated  11.62 %
Encompass Health Corporation  11.60 %
Protagonist Therapeutics inc   11.02 %
Agilent Technologies inc   10.97 %
Prestige Consumer Healthcare Inc   10.90 %
Lemaitre Vascular Inc   10.90 %
Ufp Technologies Inc   10.85 %
Progyny Inc   10.66 %
Regeneron Pharmaceuticals Inc   10.60 %
Johnson and Johnson  10.60 %
Tenet Healthcare Corp  10.49 %
Bristol myers Squibb Company  10.27 %
Solventum Corporation  10.13 %
Globus Medical Inc   10.04 %
Universal Health Services Inc   9.92 %
Entrada Therapeutics Inc   9.51 %
Amgen Inc   9.48 %
National Healthcare Corp  9.28 %
Tactile Systems Technology Inc   9.17 %

Date modified: 2026-09-12T18:09:50+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.